The role of hepatitis B surface antibodies in HBV infection, disease and clearance

Download
Citations
Altmetric
Author
Warner, N; Locarnini, S; Xu, HDate
2020-05-01Source Title
Future VirologyPublisher
FUTURE MEDICINE LTDAffiliation
Microbiology and ImmunologyDoherty Institute
Metadata
Show full item recordDocument Type
Journal ArticleCitations
Warner, N., Locarnini, S. & Xu, H. (2020). The role of hepatitis B surface antibodies in HBV infection, disease and clearance. FUTURE VIROLOGY, 15 (5), pp.293-306. https://doi.org/10.2217/fvl-2019-0147.Access Status
Open AccessAbstract
<jats:p> The clinical sequelae associated with chronic HBV infection is generally regarded as a consequence of an inadequate and inappropriate immune response to active viral replication, predominantly at the T-cell level. However, recent studies on hepatitis B surface antigen (HBsAg)-specific B cells and hepatitis B surface antibody (anti-HB) responses have identified their previously unrecognized role in the pathogenesis of chronic hepatitis B (CHB). These studies have also uncovered novel therapeutic approaches to more effectively target HBsAg loss and seroconversion, an important end point and regarded as a functional cure. Anti-HBs IgG has also been shown to have multiple direct acting antiviral roles with the Fab component directly blocking viral entry, and release while the Fc component has been linked to antibody dependent cellular cytotoxicity. Likewise, the HBsAg-specific B-cell dysfunctionality can be reversed providing new therapeutic opportunities to achieve functional cure in CHB. </jats:p>
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References